Loading clinical trials...
Loading clinical trials...
Alzheimer's disease is a condition marked by the deterioration of mental function. The disease usually begins in late middle life and results in death in 5 to 10 years. Patients with Alzheimer's disea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
NCT07666113 · Alzheimer's Disease (AD)
NCT07214727 · Alzheimer's Disease
NCT07626229 · Nervous System Diseases
NCT06745583 · Mild, Moderate, or Severe Alzheimer's Disease
NCT07040904 · Mindfulness, Alzheimer's Disease Related Dementia
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions